|
|
||||||||
From the Departments of Neurology (Drs. Amato, McVey, Cha, and Cornman) and Internal Medicine (Dr. Matthews), Wilford Hall Medical Center, San Antonio, TX; and the Departments of Medicine/Neurology (Drs. Jackson, Kleingunther, and Worley) and Pathology/Neuropathology (Dr. Kagan-Hallet), University of Texas Health Science Center at San Antonio, TX.
Received April 11, 1996. Accepted in final form May 20, 1996.
Address correspondence and reprint requests to Dr. Anthony A. Amato, Department of Medicine/Neurology, 7703 Floyd Curl Drive, San Antonio, TX 78284-7883.
Objective: To comprehensively evaluate complaints of muscle fatigue, weakness, and myalgias in Persian Gulf veterans (PGV). Background: Approximately 700,000 American troops were deployed to the Persian Gulf during Desert Shield and Desert Storm. Upon return from the Gulf, some PGV developed unexplained illnesses, and special referral centers were established for the evaluation of these patients. Among the most common symptoms of these PGV are fatigue, weakness, and myalgias. An Institute of Medicine committee recommended further exploration into the possible etiologies of these complaints. Methods: Twenty PGV with severe muscle fatigue, weakness, or myalgias that interfered with their daily activities were referred for an extensive prospective neuromuscular evaluation. Routine laboratory studies included serum creatine kinase (CK), erythrocyte sedimentation rate, thyroid function tests, and exercise forearm tests. All patients received nerve conduction studies (NCS), repetitive nerve stimulation, quantitative and single-fiber electromyography (EMG), and muscle biopsies. Results: Manual muscle strength examinations were normal in all patients. Six patients had mildly elevated CKs (range 223 to 768 IU/l); otherwise, laboratory tests were unremarkable. NCS were normal except in 2 patients with carpal tunnel syndrome. Quantitative EMGs were normal. One patient had mildly increased jitter on single-fiber EMG. Muscle biopsies demonstrated minor nonspecific abnormalities in 5 patients (i.e., increased central nuclei, rare necrotic fibers, tubular aggregates). Conclusions: Despite severe subjective symptoms, most of our patients had no objective evidence of neuromuscular disease. Mildly increased CKs or nonspecific histologic abnormalities on muscle biopsy were evident in 8 patients but were not believed to be clinically significant in most. We found no evidence of a specific neuromuscular disorder in any patient. Exposures to toxins during the Persian Gulf War were not likely responsible for our patients' symptoms.
NEUROLOGY 1997;48: 4-12
This article has been cited by other articles:
![]() |
R Salamon, C Verret, M A Jutand, M Begassat, F Laoudj, F Conso, and P Brochard Health consequences of the first Persian Gulf War on French troops Int. J. Epidemiol., April 1, 2006; 35(2): 479 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Blanchard, S. A. Eisen, R. Alpern, J. Karlinsky, R. Toomey, D. J. Reda, F. M. Murphy, L. W. Jackson, and H. K. Kang Chronic Multisymptom Illness Complex in Gulf War I Veterans 10 Years Later Am. J. Epidemiol., January 1, 2006; 163(1): 66 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Lipton, M. E. Bigal, and W. F. Stewart Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life Neurology, December 29, 2005; 65(12_suppl_4): S50 - S58. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kelsall, R. Macdonell, M. Sim, A. Forbes, D. McKenzie, D. Glass, J. Ikin, and P. Ittak Neurological status of Australian veterans of the 1991 Gulf War and the effect of medical and chemical exposures Int. J. Epidemiol., August 1, 2005; 34(4): 810 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rose, M. K. Sharief, J. Priddin, V. Nikolaou, L. Hull, C. Unwin, R. Ajmal-Ali, R. A. Sherwood, A. Spellman, A. David, et al. Evaluation of neuromuscular symptoms in UK Gulf War veterans: A controlled study Neurology, November 9, 2004; 63(9): 1681 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.B. Lipton, A.I. Scher, T.J. Steiner, M.E. Bigal, K. Kolodner, J.N. Liberman, and W.F. Stewart Patterns of health care utilization for migraine in England and in the United States Neurology, February 11, 2003; 60(3): 441 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Barohn and L. P. Rowland Neurology and Gulf War veterans Neurology, November 26, 2002; 59(10): 1484 - 1485. [Full Text] [PDF] |
||||
![]() |
M. K. Sharief, J. Priddin, R. S. Delamont, C. Unwin, M. R. Rose, A. David, and S. Wessely Neurophysiologic analysis of neuromuscular symptoms in UK Gulf War veterans: A controlled study Neurology, November 26, 2002; 59(10): 1518 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M Peden-Adams, J. Eudaly, E. Eudaly, A. Dudley, J. Zeigler, A. Lee, J. Robbs, G. Gilkeson, and D. E Keil Evaluation of immunotoxicity induced by single or concurrent exposure to N, N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel Toxicology and Industrial Health, June 1, 2001; 17(5-10): 192 - 209. [Abstract] [PDF] |
||||
![]() |
L. M. Binder, D. Storzbach, K. A. Campbell, D. S. Rohlman, W. K. Anger, M. C. Salinsky, B. R. Campbell, and R. Mueller Comparison of MMPI-2 Profiles of Gulf War Veterans with Epileptic and Nonepileptic Seizure Patients Assessment, March 1, 2000; 7(1): 73 - 78. [Abstract] [PDF] |
||||
![]() |
J. S. Stahl, L. Averbuch-Heller, B. F. Remler, and J. R. Leigh Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin Neurology, October 1, 1998; 51(4): 1093 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Chance and P. J. Dyck Hereditary neuropathy with liability to pressure palsies: A patient's point mutation in a mouse model Neurology, September 1, 1998; 51(3): 664 - 665. [Full Text] [PDF] |
||||
![]() |
Z. Sahenk, L. Chen, and M. Freimer A novel PMP22 point mutation causing HNPP phenotype: Studies on nerve xenografts Neurology, September 1, 1998; 51(3): 702 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Zhou, G.-X. Wang, B.-S. Tang, W.-D. Li, D.-A. Wang, H.-S. Lee, N. Sambuughin, L.-S. Zhou, S. Tsuji, B.-X. Yang, et al. Spinocerebellar ataxia type 2 in China: Molecular analysis and genotype-phenotype correlation in nine families Neurology, August 1, 1998; 51(2): 595 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Marrosu, S. Vaccargiu, G. Marrosu, A. Vannelli, C. Cianchetti, and F. Muntoni Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene Neurology, May 1, 1998; 50(5): 1397 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Kissel, M. P. McDermott, R. Natarajan, J. R. Mendell, S. Pandya, W. M. King, R. C. Griggs, R. Tawil, and The FSH-DY Group* Pilot trial of albuterol in facioscapulohumeral muscular dystrophy Neurology, May 1, 1998; 50(5): 1402 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Young, F. Stogbauer, H. Wiebusch, A. Lofgren, V. Timmerman, C. Van Broeckhoven, E. B. Ringelstein, G. Assmann, and H. Funke PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A Neurology, March 1, 1998; 50(3): 760 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Gabriel, B. Erne, D. Pareyson, A. Sghirlanzoni, F. Taroni, and A. J. Steck Gene dosage effects in hereditary peripheral neuropathy: Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies Neurology, December 1, 1997; 49(6): 1635 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Schonewille, S. Tuhrim, and C. Stacy Craniectomy: An aggressive treatment approach in severe encephalitis Neurology, November 1, 1997; 49(5): 1476 - 1476. [Full Text] [PDF] |
||||
![]() |
D. Pareyson, S. Botti, A. Sghirlanzoni, and F. Taroni PMP22 frameshift mutation and hereditary neuropathy with liability to pressure palsies Neurology, November 1, 1997; 49(5): 1478 - 1478. [Full Text] [PDF] |
||||
![]() |
S. Schwab Craniectomy: An aggressive treatment approach in severe encephalitis Neurology, November 1, 1997; 49(5): 1476 - 1477. [Full Text] [PDF] |
||||
![]() |
P. Young, H. Wiebusch, F. Stogbauer, B. Ringelstein, G. Assmann, and H. Funke PMP22 frameshift mutation and hereditary neuropathy with liability to pressure palsies Neurology, November 1, 1997; 49(5): 1478 - 1479. [Full Text] [PDF] |
||||
![]() |
Gulf War Syndrome: More Complex Than Middle East Politics Journal Watch Dermatology, March 1, 1997; 1997(301): 15 - 15. [Full Text] |
||||
![]() |
Gulf War Syndrome: More Complex Than Middle East Politics Journal Watch Psychiatry, March 1, 1997; 1997(301): 15 - 15. [Full Text] |
||||
![]() |
P. Young, H. Wiebusch, F. Stogbauer, B. Ringelstein, G. Assmann, and H. Funke A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies Neurology, February 1, 1997; 48(2): 450 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
GULF WAR SYNDROME: MORE COMPLEX THAN MIDDLE EAST POLITICS Journal Watch (General), January 31, 1997; 1997(131): 2 - 2. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |